Wolverine Asset Management
ACHN

Wolverine Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Wolverine Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-63,091
Closed -$380K – 1852
2019
Q4 		$380K Buy
+63,091
New +$365K ﹤0.01% 854
2015
Q1 		– Sell
-8,300
Closed -$101K – 2327
2014
Q4 		$101K Buy
8,300
+2,300
+38% +$28.1K ﹤0.01% 1193
2014
Q3 		$59K Buy
6,000
+3,800
+173% +$35.3K ﹤0.01% 1478
2014
Q2 		$16K Hold
2,200
– – ﹤0.01% 1755
2014
Q1 		$7K Sell
2,200
-32,569
-94% -$114K ﹤0.01% 1922
2013
Q4 		$115K Sell
34,769
-39,300
-53% -$114K ﹤0.01% 1391
2013
Q3 		$223K Buy
74,069
+37,769
+104% +$259K 0.01% 1116
2013
Q2 		$296K Buy
+36,300
New +$277K 0.01% 955

Wolverine Asset Management's ACHN Position: Q1 2020 in Review

Wolverine Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 63,091 shares — an estimated $380K sold.

Wolverine Asset Management first reported a position in ACHN in Q2 2013 and held it in 8 quarters. The position peaked at $380K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Wolverine Asset Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Wolverine Asset Management sold 63,091 Achillion Pharmaceuticals shares in Q1 2020, an estimated $380K.
  • Wolverine Asset Management first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Wolverine Asset Management's Achillion Pharmaceuticals position peaked at $380K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Wolverine Asset Management's 13F filing for Q1 2020, filed 13 May 2020.